A study to evaluate association of nuclear grooving in benign thyroid lesions with RET/PTC1 and RET/PTC3 gene translocation
Tóm tắt
Papillary thyroid carcinoma (PTC) is the most common malignant lesion of the thyroid characterized by unique histological features like nuclear grooving, nuclear clearing, and intra-nuclear inclusions. However, nuclear grooves are observed even in benign thyroid lesions (BTL) like nodular goiter (NG), Hashimoto's thyroiditis (HT), and follicular adenoma (FA) resulting in diagnostic dilemma of the presence of PTC in such BTL. RET/PTC gene translocation is one of the most common oncogenic rearrangements seen in PTC, known to be associated with nuclear grooving. Among different types of RET/PTC translocations, RET/PTC1 and RET/PTC3 gene translocations are the most common types. These translocations have also been identified in many BTL like hyperplastic nodules and HT. Our study aimed to determine the frequency of nuclear grooving in BTL and evaluate their association with RET/PTC1 and RET/PTC3 gene translocation. Formalin-fixed, paraffin-embedded (FFPE) tissue blocks of NG, HT, and FA were included in the study. The hematoxylin and eosin (H&E) stained sections were evaluated for the presence of nuclear grooving/high power field (hpf) and a scoring of 0 to 3 was used for the number of grooves. Sections of 10 μ thickness were cut and the cells containing the nuclear grooves were picked using Laser-Capture microdissection. About 20 to 50 such cells were microdissected in each of the cases followed by RNA extraction, cDNA conversion, realtime-polymerase chain reaction (RQ-PCR) for RET/PTC1 and RET/PTC3 gene translocation, and the findings were analyzed for statistical significance. Out of 87 BTL included in the study, 67 (77.0%) were NG, 12 (13.7%) were HT, and 8 (9.2%) were FA. Thirty-two cases (36.8%) had nuclear grooving with 18 out of 67 NG, 6 out of 12 HT, and all 8 cases of FA showing a varying number of nuclear grooves. A significant association between the number of nuclear grooves with RET/PTC gene translocation (p-value of 0.001) was obtained. A significant association of HT with RET/PTC gene translocation (p-value of 0.038) was observed. RET/PTC1 and RET/PTC3 translocation were seen in 5 out of 87 cases, with HT showing positivity in 2 and FA in 1 case for RET/PTC1 and HT in 1 and FA in 2 cases for RET/PTC3 gene translocation with 1 case of FA being positive for both RET/PTC1 and RET/PTC3 gene translocation. The frequency of nuclear grooving among BTLs in our study was 36.8%. Our study shows, that when BTLs, show nuclear grooves, with an increase in the nuclear size, oval and elongated shape, favors the possibility of an underlying genetic aberration like RET/PTC gene translocation, which in turn supports the reporting pathologist to suggest a close follow up of the patients on seeing such nuclear features on cytology or histopathology sample, particularly in HT.
Tài liệu tham khảo
Chan JK, Saw D. The grooved nucleus: a useful diagnostic criterion of papillary carcinoma of the thyroid. Am J Surg Pathol. 1986;153:1443–50.
Deligiorgi-Politi H. Nuclear crease as a cytodiognostic feature of papillary carcinoma of thyroid in fine needle aspiration biopsies. Diagn Cytopathol. 1987;3:307–10.
Scopa CD, Melachrinou M, Saradopoulou C, Merino MJ. The significance of the grooved nucleus in thyroid lesions. Mod Pathol. 1993;6(6):691–4.
Nikiforov YE. RET/PTC Rearrangement in thyroid tumors. Endocr Pathol. 2002;13:3–16.
Tallini G, Asa SL. RET oncogene activation in papillary thyroid carcinoma. Adv Anat Pathol. 2001;8:345–54.
Romei C, Elisei R. RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma. Front Endocrinol (Lausanne). 2012;3:54. https://doi.org/10.3389/fendo.2012.00054.
Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T, Nagao M. Detection of RET/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 1991;6:1667–72.
Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope. 1997;107:95–100.
Guerra A, Sapio MR, Marotta V, Campanile E, Moretti MI, Deandrea M. Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. Endocr J. 2011;58(1):31–8.
Marotta V, Guerra A, Sapio MR, Vitale M. RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. Eur J Endocrinol. 2011;165(4):499–507. https://doi.org/10.1530/EJE-11-0499.
Sapio MR, Guerra A, Marotta V, Campanile E, Formisano R, Deandrea M. High growth rate of benign thyroid nodules bearing RET/PTC rearrangements. J Clin Endocrinol Metab. 2011;96(6):E916–9.
Fischer AH, Bond JA, Taysavang P, Battles E, Wynford-Thomas D. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol. 1998;153(5):1443–50.
Rhoden KJ, Johnson C, Brandao G, Howe JG, Smith BR, Tallini G. Real-time quantitative RT-PCR identifies distinct c-RET, RET/PTC1 and RET/PTC3 expression patterns in papillary thyroid carcinoma. Lab Invest. 2004;84(12):1557–70. https://doi.org/10.1038/labinvest.3700198.
Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, et al. RET/PTC Rearrangements in Thyroid Nodules: Studies in Irradiated and Not Irradiated, Malignant and Benign Thyroid Lesions in Children and Adults. J Clin Endocrinol Metab. 2001;86(7):3211–6.
Konturek A, Barczyński M, Wierzchowski W, et al. Coexistence of papillary thyroid cancer with Hashimoto thyroiditis. Langenbecks Arch Surg. 2013;398:389–94. https://doi.org/10.1007/s00423-012-1021-x.
Gandolfi PP, Frisina A, Raffa M, Renda F, Rocchetti O, Ruggeri C, et al. The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomed. 2004;75(2):114–7.
Nikiforova MN, Caudill CM, Biddinger P, Nikiforov YE. Prevalence of RET/PTC Rearrangements in Hashimoto’s Thyroiditis and Papillary Thyroid Carcinomas. Int J Surg Pathol. 2002;10(1):15–22. https://doi.org/10.1177/106689690201000104.
Pusztaszeri MP, Krane JF, Cibas ES, Daniels G, Faquin WC. FNAB of benign thyroid nodules with papillary hyperplasia: a cytological and histological evaluation. Cancer Cytopathol. 2014;122(9):666–77.
Baloch ZW, LiVolsi VA. Current role and value of fine-needle aspiration in nodular goiter. Best Pract Res Clin Endocrinol Metab. 2014;28(4):531–44.
Lui PPY, Lee CY, Tsang D, Kong SK. Ca++ is released from the nuclear tubular structure into the nucleoplasm in C6 glioma cells after stimulation with phorbol ester. FEBS Lett. 1998;432:82–7.
Yang YJ, Demirci SS. Evaluating the diagnostic significance of nuclear grooves in thyroid fine needle aspirates with a semiquantitative approach. Acta Cytol. 2003;47(4):563–70. https://doi.org/10.1159/000326569.
Hussein O, Abdelwahab K, Hamdy O, et al. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area. J Egypt Natl Canc Inst. 2020;32:7. https://doi.org/10.1186/s43046-020-0017-9.
Prasad ML, Huang Y, Pellegata NS, de la Chapelle A, Kloos RT. Hashimoto’s thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology. 2004;45(1):39–46. https://doi.org/10.1111/j.1365-2559.2004.01876.x.
Berho M, Suster S. Clear nuclear changes in Hashimoto’s thyroiditis. A clinicopathologic study of 12 cases. Ann Clin Lab Sci. 1995;25(6):513–21.
Fiore E, et al. Hashimoto’s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer. 2011;18(4):429–37. https://doi.org/10.1530/ERC-11-0028.
Kang DY, Kim KH, Kim JM, Kim SH, Kim JY, Baik HW, Kim YS. High prevalence of RET, RAS, and ERK expression in Hashimoto’s thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid. 2007;17(11):1031–8. https://doi.org/10.1089/thy.2007.0035.
Fischer E. G: Nuclear Morphology and the Biology of Cancer Cells. Acta Cytol. 2020;64:511–9. https://doi.org/10.1159/000508780.
Kakudo K, Bychkov A, Bai Y, Li Y, Liu Z, Jung CK. The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives. Pathol Int. 2018;68(12):641–64. https://doi.org/10.1111/pin.12737.
Batistatou A, Scopa CD. Review Articles: Pathogenesis and Diagnostic Significance of Nuclear Grooves in Thyroid and Other Sites. Int J Surg Pathol. 2009;17(2):107-10. https://doi.org/10.1177/1066896908316071.